Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

NCT06109467 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

GastroEsophageal Cancer
Gastric Cancer

Interventions

DRUG: Neratinib
DRUG: Trastuzumab
DRUG: Oxaliplatin
DRUG: 5-Fluorouracil + leucovorin
DRUG: Pembrolizumab

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]